Clinical presentation {#Sec1}
=====================

A 40-year-old HIV positive man presented to the emergency department with acute onset confusion, emesis, and altered mental status. Further history revealed him to be bisexual, and a cocaine user, on chronic highly active anti-retroviral therapy (HAART) therapy. He had a history of an outbreak of herpes zoster a week ago, cryptococcal meningitis causing blindness and deafness 3 years ago, as well as Hepatitis-C, and anal condylomas. He was on chronic Co-trimoxazole (trimethoprim--sulfamethoxazole) therapy, as well as acyclovir and fluconazole. At presentation, his temperature was 36.5°C, BP 140/70 mm Hg, and pulse 75/min. The patient was mildly confused and showed mild neck stiffness. Neurologically he was drowsy but easily awakened, and did not follow two-step commands. Fundoscopy showed marked optic atrophy bilaterally. Cranial nerve examination was otherwise within normal limits. Motor exam showed normal strength and tone across all extremities. Sensory examination was within normal limits. His hemoglobin was 11 mg/dl, and white cell count was 5100/mm^3^. Lumbar puncture showed a protein level of 53 mg/dl, glucose of 49 mg/dl, and 211 nucleated cells/mm^3^ with atypical plasmacyte predominance. The patient was admitted and managed as an inpatient. CSF flowcytometry showed kappa restriction with CD8 and CD38 positivity and negative lymphocyte markers. CSF cryptococcal antigen was negative although serum cryptococcal antigen was positive at a titre of 64, with no anti-cryptococcal antibody. Serum RPR and CSF VDRL were negative and CSF AFB stain and TB PCR were also negative. The patients CD4 count was found to be 94 and viral load 18,500. Gadolinium enhanced MRI scan showed diffuse leptomeningeal enhancement, with enhancing nodules along the lateral aspect of the left cavernous sinus and left temporal pole (Fig. [1](#Fig1){ref-type="fig"}). A metastatic work up including cheat, abdomen and pelvis CT as well as a whole body PET scan failed to reveal an underlying solid tumor. An iliac crest bone marrow biopsy showed no evidence of plasma cell neoplasia. A right frontal craniotomy was performed for an en bloc diagnostic brain and meningeal biopsy. Intraoperatively the arachnoid was found to be milky and thickened. The biopsy specimen showed sheets of plasmacytoid cells with one or more large nuclei, prominent nuclear chromatin, scattered mitoses, and abundant cytoplasm, with focal extension into underlying brain parenchyma along Virchow-Robin spaces, highly suggestive of plasmablastic lymphoma (Fig. [2](#Fig2){ref-type="fig"}). Also were seen scattered nests of encapsulated cryptococci within the leptomeninges and underlying brain parenchyma with no associated inflammatory response. After two additional weeks of anti-fungal therapy for Cryptococcus, intrathecal chemotherapy was begun for his LMM with thiotepa via an Ommaya reservoir.Fig. 1Postgadolinium axial fat saturated T1W MR image shows abnormal diffuse enhancement with in the sulcii throughout the brain indicative of a diffuse leptomeningeal process (**a**). In addition there is focal nodular enhancement adjacent to the left cavernous sinus and along the left sphenoid ridge These nodules could represent granulomas or neoplastic process. Postgadolinium Coronal fat saturated T1W MR image obtained 18 days after images in **a** shows progression of the diffuse leptomeningeal process with increased hydrocephalus (**b**)Fig. 2Typical morphological features of plasmablastic lymphoma in the meningeal biopsy: sheets of plasmacytoid cells with one or more large nuclei, prominent nuclear chromatin, scattered mitoses, and abundant cytoplasm (**a** hematoxylin-eosin × 100, **b** hematoxylin-eosin × 400)

Conclusions {#Sec2}
===========

Plasmablastic lymphoma, originally described in 1997 by Delecluse et al. \[[@CR4]\] is an aggressive variant of diffuse large B-cell non-Hodgkin lymphoma seen predominantly in a setting of AIDS and nearly always in extranodal sites. Subsequently, other cases have been reported, mostly in a setting of AIDS or together with iatrogenic immune suppression or advanced age \[[@CR1]\]. Sites outside the oral cavity have been described, including the anorectal region \[[@CR2]\], skin \[[@CR10], [@CR12]\], lung \[[@CR11]\], and breast \[[@CR16]\]. One previous report has described the occurrence of a primary central nervous system (CNS) PBL in an AIDS patient as a well-defined, hyperdense, contrast enhancing mass in the right basal ganglia with extensive peritumoral edema and mass effect \[[@CR13]\]. Our report is the first to describe the previously unrecognized primary leptomeningeal form of PBL in an AIDS patient. Interestingly this was associated with CNS cyptococcosis suggesting a role for chronic antigen stimulation in its pathogenesis. Such association of NHLs with chronic infection including viral infections (EBV, HHV8) as well as chronic tuberculous pyothorax is known to occur \[[@CR9]\].

Lymphomas in HIV patients are heterogenous and reflect several pathogenetic mechanisms such as chronic antigen stimulation, multiple genetic alterations, and cytokine dysregulation. Based on a similar morphology and behavior, plasmablastic lymphoma needs to be distinguished from the immunoblastic variant of diffuse large B-cell lymphoma, classic (body cavity-based) and solid (extracavitary) variants of primary effusion lymphoma, Burkitt lymphoma with plasmacytoid differentiation, and extramedullary plasmablastic tumors secondary to multiple myeloma or plasmacytomas. Plasmablastic lymphoma is characterized by immunoblastic morphology and plasma cell phenotype. In other words, plasmablasts are lymphoid cells that morphologically resemble B-cell immunoblasts but have acquired a plasma cell immunophenotype (i.e, loss of B-cell markers and surface immunoglobulin with the acquisition of plasma cell surface markers) \[[@CR13]\]. Thus, unlike immunoblasts, plasmablasts fail to express CD45 (leukocyte common antigen) as well as the B-cell marker CD20 and are only variably immunoreactive for CD79a--a broader-spectrum B-cell marker. They are also negative for pan-T-cell markers. Positive staining for plasma cell markers such as VS38c, CD38, MUM-1, and CD138 indicates a phenotype akin to plasma cells \[[@CR13]\]. PBL has been etiologically linked to Epstein-Barr virus, Kaposi Sarcoma human virus, and human herpesvirus type-8 infections in addition to HIV \[[@CR3], [@CR5]\]. Microscopic examination shows infiltrates of large atypical plasmacytoid cells with abundant cytoplasm, round nuclei, and occasional, centrally located, prominent nucleoli \[[@CR14]\]. Several different immunohistochemical markers have been used in an attempt to characterize these lesions \[[@CR6]\]. Of these CD 138 is most consistently positive and indicates plasma cell differentiation of the tumor cells \[[@CR6], [@CR8]\]. Immunoglobin heavy and light chain restrictions are often present \[[@CR2], [@CR15]\]. Ultrastructural features under electron microcopy include round nuclei with clumped heterochromatin and large nucleoli, with concentrically arranged rough endoplasmic reticulum in the cytoplasm \[[@CR7]\].

HIV associated PBL has been treated with a variety of chemotherapeutic agents, but the efficacy of treatment is unclear. The previously reported case of CNS PBL was treated with intrathecal methotrexate but the patient was lost to follow up and the outcome is uncertain \[[@CR15]\]. Published reports indicate that these are aggressive tumors, frequently resistant to therapy, and often rapidly fatal.
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